QINGDAO, China, Sept. 8, 2026 /PRNewswire/ -- A news report from Iqingdao:
In autumn, red-tiled roofs and leafy green trees line the lanes and alleyways of Qingdao's historic old town, while the sea breeze carries the first hints of laughter and joy. Officially scheduled for September 19–28, the 3rd Qingdao Liyuan Comedy Festival will take place in the old town's Liyuan neighborhood, known for its distinctive courtyard-style residential compounds. Spanning a full range of comedy genres and settings, the festival will offer residents and visitors of all ages a spectacular celebration of comedy.
A major expansion in both lineup and scale is one of this year's highlights. The festival will feature more than 26 comedy formats, including stand-up, improv, stage plays, manzai—Japanese-style double-act comedy—and mime. New participating groups and productions will account for as much as 80 percent of the program. The international lineup will include Denmark's Paolo Nani Theatre and Australia's Loading Zone Comedy, both presenting world-class comedy productions. The lineup from across China will be equally star-studded, with leading comedy companies such as Mahua FunAge—including its stand-up and improv productions—Danliren Comedy, Huishuoxiao Comedy and Xiaoguo Culture all taking part. Qingdao-based groups such as Clam Comedy and HuiXiao Comedy will also make high-profile appearances.
Qingdao Liyuan Comedy Festival Gears Up
According to the event organizer, the festival will continue to build on its core theme, "A Street of Great Shows," while maintaining its commitment to broad public participation and a strong local character. Combining professional performances with audience interaction, it will build an integrated experience encompassing performances, interaction, cultural consumption and co-creation, helping comedy take root in the urban fabric. More than a short-term performing arts event, the festival is a vivid example of culture-led neighborhood revitalization as part of the ongoing regeneration of Qingdao's historic old town. Through laughter, it will breathe new life into historic buildings and foster a distinctive local "laughter economy."
From a single historic street to an entire comedy district, and from performances on stage to immersive festivities throughout the surrounding lanes and alleyways, the 3rd Qingdao Liyuan Comedy Festival will fill the city with joy and surprise this autumn. With one great show after another, it will further strengthen Qingdao's identity as a vibrant cultural destination and bring unexpected moments of delight to everyone who attends.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Laughter Is in the Air, with Surprises at Every Turn! The 3rd Qingdao Liyuan Comedy Festival Gears Up
- PDRN Derma cream, serum, and mask lineup positions premium K-dermocosmetics based on patented ingredients for Southeast Asian market expansion
CHUNCHEON, South Korea, Sept. 8, 2026 /PRNewswire/ -- K-Medichem Co., Ltd. (K-Medichem), a Korean biotech company built on university research, is accelerating its sales expansion across Vietnam, Indonesia, and other global markets with the PDRN skincare range from its premium brand, DAYNICS. With interest in skin-barrier and sensitive skin care surging across Southeast Asia, K-Medichem aims to strengthen its global strategy by delivering science-based, functional K-dermocosmetics that prioritize efficacy and safety.
K-Medichem's premium derma skincare brand DAYNICS' PDRN-Madeca Derma Cream, formulated with plant-derived PDRN, madecassoside, and K-Medichem's proprietary patented ingredient NCT.
Developed through advanced biomaterial technology and university R&D, DAYNICS is dedicated to restoring the skin's inherent health. Moving beyond basic moisturization, the brand offers a multifunctional derma-care solution designed to support skin barrier care, renewal, conditioning, soothing, and antioxidant protection.
The flagship product, DAYNICS PDRN-Madeca Derma Cream, features plant-derived polydeoxyribonucleotide (PDRN), madecassoside, and N-Caffeoyl Tyramine (NCT)—a patented ingredient independently developed by K-Medichem. Plant-derived PDRN supports skin regeneration, tissue recovery, and barrier reinforcement. Madecassoside, derived from Centella asiatica, helps soothe skin sensitized by external stimuli. Furthermore, K-Medichem's proprietary NCT protects the skin from oxidative stress caused by UV exposure and fine dust through powerful antioxidant activity. These three key ingredients work synergistically in a skin-friendly formulation to provide intensive moisturization, soothing care, and skin-renewal support.
Complementing the cream, K-Medichem has launched the DAYNICS PDRN-Madeca Derma Serum and DAYNICS PDRN-Madeca Derma Serum Mask to complete its premium skincare lineup. The serum delivers concentrated active ingredients for intensive nourishment, while the mask serves as an intensive-care treatment for targeted hydration and barrier recovery. Together, these products form a comprehensive daily skincare routine.
As an R&D-focused enterprise, K-Medichem continually commercializes university research outcomes into differentiated dermocosmetics. Building on this expertise, the company plans to steadily expand its distribution network across Southeast Asia and into broader global markets.
DAYNICS is a premium bio-derma skincare brand developed on the basis of advanced technology and patented functional ingredients, said a K-Medichem representative. K-Medichem will continue to expand their PDRN Derma lineup, strengthen cooperation with local distribution partners, and grow DAYNICS into a trusted K-derma brand globally.
1. Official Website
http://www.skinmedichem.co.kr/
2. Instagram
https://www.instagram.com/kmedichem
3. YouTube
https://www.youtube.com/@Kmedichem
CHUNCHEON, South Korea, Sept. 8, 2026 /PRNewswire/ -- K-Medichem Co., Ltd. (K-Medichem), a Korean biotech company built on university research, is accelerating its sales expansion across Vietnam, Indonesia, and other global markets with the PDRN skincare range from its premium brand, DAYNICS. With interest in skin-barrier and sensitive skin care surging across Southeast Asia, K-Medichem aims to strengthen its global strategy by delivering science-based, functional K-dermocosmetics that prioritize efficacy and safety.
K-Medichem's premium derma skincare brand DAYNICS' PDRN-Madeca Derma Cream, formulated with plant-derived PDRN, madecassoside, and K-Medichem's proprietary patented ingredient NCT.
Developed through advanced biomaterial technology and university R&D, DAYNICS is dedicated to restoring the skin's inherent health. Moving beyond basic moisturization, the brand offers a multifunctional derma-care solution designed to support skin barrier care, renewal, conditioning, soothing, and antioxidant protection.
The flagship product, DAYNICS PDRN-Madeca Derma Cream, features plant-derived polydeoxyribonucleotide (PDRN), madecassoside, and N-Caffeoyl Tyramine (NCT)—a patented ingredient independently developed by K-Medichem. Plant-derived PDRN supports skin regeneration, tissue recovery, and barrier reinforcement. Madecassoside, derived from Centella asiatica, helps soothe skin sensitized by external stimuli. Furthermore, K-Medichem's proprietary NCT protects the skin from oxidative stress caused by UV exposure and fine dust through powerful antioxidant activity. These three key ingredients work synergistically in a skin-friendly formulation to provide intensive moisturization, soothing care, and skin-renewal support.
Complementing the cream, K-Medichem has launched the DAYNICS PDRN-Madeca Derma Serum and DAYNICS PDRN-Madeca Derma Serum Mask to complete its premium skincare lineup. The serum delivers concentrated active ingredients for intensive nourishment, while the mask serves as an intensive-care treatment for targeted hydration and barrier recovery. Together, these products form a comprehensive daily skincare routine.
As an R&D-focused enterprise, K-Medichem continually commercializes university research outcomes into differentiated dermocosmetics. Building on this expertise, the company plans to steadily expand its distribution network across Southeast Asia and into broader global markets.
DAYNICS is a premium bio-derma skincare brand developed on the basis of advanced technology and patented functional ingredients, said a K-Medichem representative. K-Medichem will continue to expand their PDRN Derma lineup, strengthen cooperation with local distribution partners, and grow DAYNICS into a trusted K-derma brand globally.
1. Official Website
http://www.skinmedichem.co.kr/
2. Instagram
https://www.instagram.com/kmedichem
3. YouTube
https://www.youtube.com/@Kmedichem
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Korean Biotech Company K-Medichem Expands Global Market Reach with PDRN Derma Skincare Line in Vietnam, Indonesia and Beyond